← Back to SMAs vs TAMPs Guide

Fidelity Advisor Health Care SMA

Analyzing Fidelity's healthcare sector strategy and SharpeMetrix's cross-sector alternative data approach

Strategy Overview

Benchmark

MSCI U.S. IMI Health Care 25/50

Holdings Target

40–80 Stocks

Management Team

  • Eddie Yoon - Lead Portfolio Manager
  • Anthony Italiano, CFA

Investment Approach

The Fidelity Advisor Health Care SMA seeks to invest in health care companies across the spectrum, ranging from high-quality, stable earnings growers to opportunistic names producing innovative products that disrupt the marketplace. The strategy provides targeted exposure to the healthcare sector with flexibility to capitalize on both defensive and growth opportunities.

Key Strategy Characteristics

  • Diversified healthcare exposure from pharmaceuticals to biotechnology to medical devices
  • Balances defensive, stable earners with innovative disruptors
  • Leverages Fidelity's deep healthcare research capabilities
  • Concentrated approach allows for meaningful position sizing in best ideas

Risk Considerations

  • • Healthcare sector subject to government regulation and reimbursement rate changes
  • • Product approvals can significantly impact company valuations
  • • Rapid obsolescence and patent expirations create ongoing risks
  • • Sector concentration may result in additional volatility
  • • Biotech names can experience extreme price swings based on clinical trial results

Consider a Data-Driven Systematic Alternative

While sector-specific SMAs offer targeted exposure, SharpeMetrix provides diversified, cross-sector portfolios powered by alternative data—capturing opportunities wherever they exist.

Cross-Sector Opportunities

Rather than limiting exposure to a single sector, our models dynamically allocate across sectors based on where our signals identify the best risk-adjusted returns.

Flat-Fee Pricing

Unlike traditional SMAs with asset-based fees, SharpeMetrix offers transparent flat-fee pricing that scales with your practice.

Innovation Detection

Our Innovation Signal uses patent and H1B visa data to identify companies—including healthcare innovators—with sustainable competitive advantages.

Try SharpeMetrix Free

SharpeMetrix Model Portfolios

Compare our systematic, data-driven portfolios with live performance metrics

Model Portfolio Universe Holdings Annual Return Excess Return Sharpe Ratio View
SharpeMetrix Core Alpha 30
 Russel 1000 29 17.6% 6.0% 0.85 View Details
SharpeMetrix Small Cap Edge 30
 Russel 2000 29 18.7% 8.6% 0.81 View Details
SharpeMetrix Small Cap Edge 50
 Russel 2000 49 19.2% 9.1% 0.86 View Details
SharpeMetrix Large Cap Earnings
 S&P 500 39 13.7% 1.6% 0.71 View Details
SharpeMetrix Large Cap 50
 S&P 500 49 16.8% 4.6% 0.92 View Details
SharpeMetrix Core Alpha 50
 Russel 1000 49 17.2% 5.6% 0.88 View Details
SharpeMetrix Small Cap Value Edge
 Russel 2000 39 19.0% 8.9% 0.66 View Details
SharpeMetrix Russell 1000 Momentum
 Russel 1000 39 16.4% 4.8% 0.77 View Details
SharpeMetrix Large Cap 30
 S&P 500 29 16.4% 4.3% 0.87 View Details

Explore More Fidelity SMAs

Fidelity Advisor International Capital Appreciation SMA

MSCI ACWI ex-USA | 40-80 Holdings

Fidelity Advisor International Growth SMA

MSCI EAFE Growth | 40-80 Holdings

Fidelity Advisor Growth Opportunities SMA

Russell 1000 Growth | 40-80 Holdings

Fidelity Advisor Large Cap Opportunities SMA

S&P 500 | 70-100 Holdings

Fidelity Advisor Small Company SMA

Russell 2000 | 60-100 Holdings

View All SMAs Comparison

Complete guide to SMAs vs TAMPs